NCT04244630 - Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 2, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Interventions

COMBINATION_PRODUCT

Antioxidants

Over-the-counter anti-oxidants, namely vitamin E, NAc cysteine, L-cystine, Nicotinamide and Taurursodiol at defined doses

Trial Locations (1)

RECRUITING

VA North Texas Health Care System, Dallas